Crisis: Medical Marijuana, Inc. Featured in Documentary Film About Historic Cannabis Access by Families and Children in Mexico

Crisis Produced by CMW Media, Portrays the Legal Struggle of Parents in Mexico Who Are Leading the Battle for Access to Cannabis for Health as a Constitutional Right

San Diego, CA – May 13, 2016 – Medical Marijuana, Inc. (OTC: MJNA) is pleased to announce to shareholders and the public that the Company and its subsidiaries are featured in a documentary Crisis premiering in Mexico next week.

Award-winning producer Jordan Guzzardo and photojournalist Christian Rodas of CMW Media accompanied Mexican father Abelardo Maldonado on Feb. 2 to COFEPRIS in Mexico City, to document the historic day as Maldonado picked up the first-ever federal import permit issued for a cannabis product. On that day, Maldonado picked up his COFEPRIS import permit for Medical Marijuana, Inc.’s cannabidiol (CBD) hemp oil product Real Scientific Hemp Oil-X™ (RSHO-X™), for his 11-year-old daughter Alina.

The family of Grace Elizalde, who’s diagnosed with Lennox Gestalt Syndrome, created the legal precedent for Alina to import RSHO-X™. The Elizalde family was the first in Mexico to sue the federal government and win the right to import CBD hemp oil. Grace was subjected to several different treatment protocols – 19 in all – with no lasting success.

Raul Elizalde and his wife Mayela Elizalde Benevides have since created a non-profit organization, http://www.porgrace.org.mx, to assist other families in Mexico with access to cannabis for health conditions. Hundreds of families from across the country have joined forces to access cannabis through PorGrace.org.

While it didn’t legalize marijuana, a November 2015 Mexico Supreme Court ruling paved the way for future rulings that could lead to full-scale marijuana legalization. After the ruling, Mexico held a series of regional town hall discussions across the country beginning in January and concluding in April, 2016. CMW Media’s footage in Crisis includes commentary from some of the families who attended the forums. Many share their heart-wrenching accounts of attempts to access cannabis for their children’s health conditions.

As the debates took place across the country, on Feb. 2 the Health Department of Mexico, COFEPRIS, issued the country’s first-ever government permits to import RSHO-X™, to Maldonado’s daughter Alina and also to 5-year-old Maria Paula. These were the first import permits in Mexico’s history allowing importation of non-psychoactive cannabis oil.

All of these historic events are included in the documentary Crisis that is being released for distribution at a live press conference held in Mexico City on Monday, May 16. The producers of Crisis will be available for comment during the press conference. For information on CMW Media, visit the company’s website at www.cmwmedia.com.

About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

For further information, please contact:

Public Relations contact:

Andrew Hard

CEO

CMW Media

888-829-0070

[email protected]

www.cmwmedia.com

Corporate Contact:

Medical Marijuana, Inc.

Toll Free: 888-OTC-MJNA (888-682-6562)

www.medicalmarijuanainc.com